To test this hyphothesis, we employ siRNA technology in the triple-negative MDA-MB-231 and in the hormone-receptor positive MCF-7 breast cancer cell lines to assess the molecular function of Syndecan-1. Here, SDC1 is linked to breast carcinoma.